Related Experiment Video
Updated: Aug 7, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Immunotherapy for prostate cancer: what's the future?
Philip M Arlen1, William L Dahut, James L Gulley
1Clinical Research Group, Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, MSC 1750, Bethesda, MD 20892-1750, USA. pa52s@nih.gov
Hematology/Oncology Clinics of North America
|July 25, 2006
Summary
Advancements in prostate cancer vaccines, including antibody-based and cellular therapies, are improving treatment outcomes. This review covers current strategies and combination approaches for prostate cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Prostate cancer is a leading cause of cancer death in US men.
- Advances in immunology have spurred the development of novel prostate cancer therapies.
- Immunotherapy offers a promising avenue for improving treatment efficacy.
Purpose of the Study:
- To discuss the rationale behind antibody-based and vaccine therapies for prostate cancer.
- To summarize clinical studies of various prostate cancer immunotherapy strategies.
- To explore novel approaches combining immunotherapy with traditional treatments.
Main Methods:
- Review of scientific literature on prostate cancer immunotherapy.
- Discussion of antibody-based therapies.
- Analysis of vaccine strategies including whole tumor cells, dendritic cells, and viral vectors.
- Summary of clinical trial data.
- Exploration of combination therapies.
Main Results:
- Multiple immunotherapy strategies are under investigation for prostate cancer.
- Clinical studies show varied efficacy for different approaches.
- Combination therapies integrating immunotherapy with conventional treatments are emerging.
Conclusions:
- Immunotherapy, including antibody and vaccine-based approaches, holds significant promise for prostate cancer treatment.
- Further research and clinical trials are essential to optimize these strategies.
- Combination immunotherapy represents a key future direction for managing prostate cancer.
More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...